Recent Posts
- New study finds sexual dysfunction is common in scleroderma
- EBV infections may affect risk of developing scleroderma: Analysis
- Clumps of modified stem cells seen to ease skin, lung scarring in mice
- Efzofitimod found safe, well tolerated in study of SSc-ILD
- Study shows immune signaling protein IL-40 is also involved in SSc
- First SSc patient dosed in Phase 1 trial of CAR T-cell therapy
- National Scleroderma Foundation recognizes outstanding chapters
- Developing a plan is helpful when dealing with medical uncertainty
- SRF joins capital effort to advance drug development for scleroderma
- Scientists ID 4 SSc-ILD subtypes to better predict patient outcomes